Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Escherichia coli cellulitis: two cases.

J Castanet1, J P Lacour, C Perrin

  • 1Department of Dermatology, University of Nice, France.

Acta Dermato-Venereologica
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project.

ESMO open·2024
Same author

Improved nationwide survival of sarcoma patients with a network of reference centers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.

ESMO open·2023
Same journal

A Facial Lesion with Cord-like Induration and Ring-like Appearance on MRI: A Quiz.

Acta dermato-venereologica·2026
Same journal

Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study.

Acta dermato-venereologica·2026
Same journal

An 8-year-old Girl with Multiple Whitish Dots on the Hair Shaft: A Quiz.

Acta dermato-venereologica·2026
Same journal

A Congenital Subcutaneous Tumour of the Scalp in a Child: A Quiz.

Acta dermato-venereologica·2026
Same journal

Commentary on: "The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma".

Acta dermato-venereologica·2026
Same journal

Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study.

Acta dermato-venereologica·2026
See all related articles

Escherichia coli (E. coli) leg cellulitis is rare but may be underdiagnosed. Prompt identification and broad-spectrum antibiotics are crucial for patients with risk factors.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Dermatology

Background:

  • Cellulitis is a common bacterial skin infection, typically caused by Staphylococcus or Streptococcus.
  • Gram-negative bacilli, such as Escherichia coli (E. coli), are infrequently reported as causative agents of cellulitis.
  • The specific bacterial cause of cellulitis is often not identified in clinical practice.

Observation:

  • This report details two adult cases of leg cellulitis where E. coli was identified as the likely pathogen.
  • These cases highlight the potential for E. coli to cause cellulitis, a condition rarely associated with this bacterium.
  • The patients presented with leg cellulitis, suggesting a localized infection by E. coli.

Findings:

  • E. coli cellulitis, though rare, can occur in adults.

Related Experiment Videos

  • The identification of E. coli as a cause of cellulitis may be missed in routine diagnostics.
  • Gram-negative bacterial infections, including E. coli cellulitis, can have severe or fatal outcomes, particularly in immunocompromised individuals.

    • Implications:

    • Healthcare providers should consider E. coli and other gram-negative bacilli in the differential diagnosis of cellulitis, especially in at-risk patients.
    • Diagnostic efforts to identify the causative microorganism in cellulitis cases are warranted.
    • Empirical treatment with broad-spectrum antibiotics should be initiated promptly in patients with risk factors for severe gram-negative infections presenting with cellulitis.